Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroendocrine Tumor Therapy with Lutetium-177: A Literature Review
Muhammad Haisum Maqsood, Asim Tameez Ud Din, Ameer Khan
Cureus (2019)
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
Brendan J. Evans, Andrew T. King, Andrew Katsifis, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2314-2314
Open Access | Times Cited: 107
Molecular Imaging and Therapy for Neuroendocrine Tumors
Hemant Desai, Salvador Borges‐Neto, Terence Z. Wong
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 10
Closed Access | Times Cited: 59
Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management
Chengyue Jin, Ajay Sharma, Balasingam Thevakumar, et al.
Cardiology (2020) Vol. 146, Iss. 1, pp. 65-73
Open Access | Times Cited: 52
Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability
Thomas Günther Pomorski, Sandra Deiser, Veronika Felber, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 9, pp. 1364-1370
Open Access | Times Cited: 27
Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors
Sara Elena Campos Ramírez, Alejandro Andrés Gracia, Carmen Blanco Abad, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2384-2384
Open Access
Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy
Dhanashree Murugan, Harashkumar Vasanthakumari Thirumalaiswamy, Vasanth Murugesan, et al.
Pharmacology & Therapeutics (2025), pp. 108863-108863
Closed Access
177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
Shilpa Thakur, Brianna Daley, Corina Millo, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 5, pp. 1399-1409
Open Access | Times Cited: 26
86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics
Carolina A. Ferreira, Emily B. Ehlerding, Zachary T. Rosenkrans, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 5, pp. 1697-1705
Open Access | Times Cited: 23
Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
Estephany Abou Jokh Casas, Virginia Pubul Núñez, Urbano Anido, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 13, pp. 1513-1524
Open Access | Times Cited: 23
Preclinical Evaluation of68Ga- and177Lu-Labeled Integrin αvβ6-Targeting Radiotheranostic Peptides
Tanushree Ganguly, Nadine Bauer, Ryan A. Davis, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 639-644
Open Access | Times Cited: 13
Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
Tiago Silva, Marie‐Louise F. van Velthuysen, Casper H.J. van Eijck, et al.
Endocrinology Diabetes and Metabolism Case Reports (2018) Vol. 2018
Open Access | Times Cited: 17
Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the 68Zn(p,n)68Ga Reaction and Their Regulatory Aspects
Zarif Ashhar, Muhammad Fakhrurazi Ahmad Fadzil, Muhamad Faiz Othman, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 70-70
Open Access | Times Cited: 9
Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225
Dayana Castillo Seoane, Marijke De Saint‐Hubert, Melissa Crabbé, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging (2020) Vol. 64, Iss. 3
Closed Access | Times Cited: 11
Long-Term Follow-Up of a Patient with Primary Presacral Neuroendocrine Tumor: A Case Report with Literature Review
Mi Ra Kim, Hye‐kyung Shim
American Journal of Case Reports (2019) Vol. 20, pp. 1969-1975
Open Access | Times Cited: 8
Continuing challenges of primary neuroendocrine tumours of the thymus: A concise review
Joel Wen Liang Lau, Titus Cvasciuc, Duncan Simpson, et al.
European Journal of Surgical Oncology (2022) Vol. 48, Iss. 12, pp. 2360-2368
Closed Access | Times Cited: 3
Extraction of REE(III) and Am(III) from a Nitric Acid Solution with Fe(III) and Mn(II) Dibutyl Phosphoric Acid Compounds
D. N. Shishkin, N. D. Goletskii
Radiochemistry (2024) Vol. 66, Iss. 6, pp. 810-816
Closed Access
68Ga-DOTATATE PET/CT Imaging of Refractory Pituitary Macroadenoma Invading the Orbit
Noah Lybik, Daniel J. Wale, Ka Kit Wong, et al.
Clinical Nuclear Medicine (2021) Vol. 46, Iss. 6, pp. 505-506
Closed Access | Times Cited: 3
Production route analysis of a therapeutic radionuclide 177Lu
A. K. M. Rezaur Rahman, Rifat Amin
AIP Advances (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 2
Technological challenges of theranostics in oncology
Sanjoy Das, Malay K. Das
Elsevier eBooks (2021), pp. 307-344
Closed Access | Times Cited: 2
Treatment of Neuroendocrine Tumors (NETs) Using Somatostatin Analogs: Current View, Clinical Achievements and Future Perspectives
Hendris Wongso
Indonesian Journal of Cancer Chemoprevention (2019) Vol. 10, Iss. 2, pp. 101-101
Open Access | Times Cited: 1
Chilean experience using “Theranostics” for treating metastatic neuroendocrine tumors with [177Lu]Lu DOTA-TATE
Amaral Horacio
Archives of Clinical Gastroenterology (2020), pp. 036-040
Open Access | Times Cited: 1
Metastasis: A Major Driver of Cancer Pathogenesis
Pradeep Singh Cheema, Gaurav Kumar, Sonam Mittal, et al.
Springer eBooks (2020), pp. 185-211
Closed Access | Times Cited: 1
Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report
Susann Groschke, Rolf Weinert, Björn Becker, et al.
Journal of Medical Case Reports (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Practical Guidance on Peptide Receptor Radionuclide Therapy
Emre Demirci, Nalan Alan Selçuk, Levent Kabasakal, et al.
Nuclear Medicine Seminars (2020) Vol. 6, Iss. 3, pp. 406-415
Open Access | Times Cited: 1
Data from <sup>177</sup>Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
Shilpa Thakur, Brianna Daley, Corina Millo, et al.
(2023)
Open Access
Page 1 - Next Page

Scroll to top